Natixis Investment Managers International Dexcom Inc Transaction History

Natixis Investment Managers International

$1.29 Billion
Q4 2024

A detailed history of Natixis Investment Managers International transactions in Dexcom Inc stock. As of the latest transaction made, Natixis Investment Managers International holds 2,883 shares of DXCM stock, worth $242,431. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,883

Previous 2,531 13.91%

Holding current value

$242,431

Previous $169,000 32.54%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $23,119 - $28,515	352 Added 13.91%	2,883 $224,000
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $17.5 Million - $31.8 Million	-273,965 Reduced 99.08%	2,531 $169,000
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $3.75 Million - $4.78 Million	34,005 Added 14.02%	276,496 $31.3 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $2.61 Million - $3.2 Million	22,853 Added 10.4%	242,491 $33.6 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $1.67 Million - $2.74 Million	-22,094 Reduced 9.14%	219,638 $27.3 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $20.6 Million - $32.9 Million	238,844 Added 8270.22%	241,732 $22.6 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $7,085 - $8,251	63 Added 2.23%	2,888 $371,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $58,552 - $69,203	-563 Reduced 16.62%	2,825 $328,000
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $106,225 - $153,337	-1,250 Reduced 26.95%	3,388 $383,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $890,393 - $1.1 Million	-11,662 Reduced 71.55%	4,638 $373,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.01 Million - $1.98 Million	14,866 Added 1036.68%	16,300 $1.21 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $78,462 - $108,586	834 Added 139.0%	1,434 $733,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $10,389 - $13,025	80 Added 15.38%	600 $322,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $3,201 - $4,295	-30 Reduced 5.45%	520 $284,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $11,743 - $15,649	145 Added 35.8%	550 $234,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $1,356 - $1,675	-16 Reduced 3.8%	405 $145,000
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $32,838 - $43,994	421 New	421 $155,000
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $32,915 - $45,524	-2,960 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $33,625 - $56,180	2,960	2,960 $145,000

Others Institutions Holding DXCM

# of Institutions

1,059

Shares Held

342M

Call Options Held

5.79M

Put Options Held

5.74M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.

Account

Natixis Investment Managers International Dexcom Inc Transaction History